CFO
Callan Family Office Portfolio holdings
AUM
$3.17B
This Quarter Return
+5.61%
1 Year Return
+21.62%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$379M
AUM Growth
+$379M
(-8%)
Cap. Flow
-$53.8M
Cap. Flow
% of AUM
-14.19%
Top 10 Holdings %
Top 10 Hldgs %
65.17%
Holding
161
New
8
Increased
29
Reduced
62
Closed
51
Top Buys
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
$1,000K |
| 2 |
Vanguard S&P 500 ETF
VOO
|
$753K |
| 3 |
iShares Core S&P 500 ETF
IVV
|
$654K |
| 4 |
iShares Russell 2000 ETF
IWM
|
$545K |
| 5 |
iShares Russell 1000 Growth ETF
IWF
|
$461K |
Top Sells
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
$2.89M |
| 2 |
Microsoft
MSFT
|
$2.61M |
| 3 |
Alphabet (Google) Class C
GOOG
|
$2.47M |
| 4 |
Occidental Petroleum
OXY
|
$1.6M |
| 5 |
Wells Fargo
WFC
|
$1.57M |
Sector Composition
| 1 | Technology | 3.84% |
| 2 | Financials | 2.84% |
| 3 | Healthcare | 1.16% |
| 4 | Industrials | 0.99% |
| 5 | Consumer Staples | 0.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Elanco Animal Health
ELAN
$9.12B
| – | – |
-11,500
| Closed | -$108K |
|
127
FedEx
FDX
$54.5B
| – | – |
-5,715
| Closed | -$1.31M |
|
128
Fox Class A
FOXA
$26.6B
| – | – |
-8,000
| Closed | -$272K |
|
129
GE Aerospace
GE
$292B
| – | – |
-9,333
| Closed | -$892K |
|
130
GE HealthCare
GEHC
$33.7B
| – | – |
-4,899
| Closed | -$402K |
|
131
Gilead Sciences
GILD
$140B
| – | – |
-13,778
| Closed | -$1.14M |
|
132
GSK
GSK
$79.9B
| – | – |
-25,900
| Closed | -$922K |
|
133
W.W. Grainger
GWW
$48.5B
| – | – |
-500
| Closed | -$344K |
|
134
Haleon
HLN
$43.9B
| – | – |
-41,900
| Closed | -$341K |
|
135
iShares Russell 2000 Value ETF
IWN
$11.8B
| – | – |
-2,752
| Closed | -$377K |
|
136
Johnson Controls International
JCI
$69.9B
| – | – |
-17,745
| Closed | -$1.07M |
|
137
Microchip Technology
MCHP
$35.1B
| – | – |
-14,563
| Closed | -$1.22M |
|
138
Mondelez International
MDLZ
$79.5B
| – | – |
-4,019
| Closed | -$280K |
|
139
Medtronic
MDT
$119B
| – | – |
-5,811
| Closed | -$468K |
|
140
MetLife
MET
$54.1B
| – | – |
-14,542
| Closed | -$843K |
|
141
Marsh & McLennan
MMC
$101B
| – | – |
-1,374
| Closed | -$229K |
|
142
Nike
NKE
$114B
| – | – |
-2,134
| Closed | -$262K |
|
143
Novartis
NVS
$245B
| – | – |
-9,605
| Closed | -$884K |
|
|
144
Occidental Petroleum
OXY
$46.9B
| – | – |
-25,651
| Closed | -$1.6M |
|
145
Regeneron Pharmaceuticals
REGN
$61.5B
| – | – |
-786
| Closed | -$646K |
|
146
ResMed
RMD
$40.2B
| – | – |
-1,034
| Closed | -$226K |
|
147
Invesco S&P SmallCap 600 Pure Value ETF
RZV
$224M
| – | – |
-4,189
| Closed | -$380K |
|
148
Starbucks
SBUX
$100B
| – | – |
-2,051
| Closed | -$214K |
|
149
Sanofi
SNY
$121B
| – | – |
-24,800
| Closed | -$1.35M |
|
150
S&P Global
SPGI
$167B
| – | – |
-708
| Closed | -$244K |
|